Prescribing of Rosiglitazone and Pioglitazone Following Safety Signals: Analysis of Trends in Dispensing Patterns in the Netherlands from 1998 to 2008

By Ruiter Rikje   Visser Loes E.   van Herk-Sukel Myrthe P.P.  

Drug Safety, Vol. 35, Iss. 6, 2012-06 ,pp. : 471-480

Adis International

Access to resources Recommend Favorite

Clinical Impact of Adjuvant Chemotherapy in Glioblastoma Multiforme: A Meta-Analysis

By Spiegel Brennan M.R.   Esrailian Eric   Laine Loren  

CNS Drugs, Vol. 21, Iss. 9, 2007-01 ,pp. : 775-787

Adis International

Access to resources Recommend Favorite

Antihyperglycaemics: prescribing rate unchanged by rosiglitazone warning

By  

Reactions Weekly, Vol. 1, Iss. 1282, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Uses and abuses of meta-analysis

By Egger Matthias   Smith George Davey   Sterne Jonathan A C  

Clinical Medicine, Vol. 1, Iss. 6, 2001-11 ,pp. : 478-484

Royal College Of Physicians

Access to resources Recommend Favorite

Impact of the UGT1A1*28 allele on response to irinotecan: a systematic review and meta-analysis

By Dias Mafalda M   McKinnon Ross A   Sorich Michael J  

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 889-899

Future Medicine

Access to resources Recommend Favorite